Micregen  is a private UK registered company wholly owned by Micregen founders, private family office, angel investors and life science professionals. Controlled by the founders and managed by a Board with considerable industry experience and business expertise. ​​

Since Micregen’s CSO’s pioneering discoveries in 1993 and a series of unconventional scientific breakthroughs over many years of stem cell research experience since, Micregen believe that they have uncovered certain secrets that originally flew against convention. This has allowed Micregen time to progress its technology relatively undetected for several years.

Careful use of funds to date and strong academic, clinical, and industry support has allowed Micregen to progress both MRG1061 and MRG1161 towards clinical trials. ​ 

Micregen  has two wholly owned subsidiaries MRG1061 Ltd and MRG1161 Ltd. These companies are registered to manage Micregen’s first two therapeutics MRG1061, aimed at neonatal indications and MRG1161, for degenerative conditions associated with ageing.


We welcome interest from potential investors who would like to know more about our cutting edge innovation.

Making an Impact Investment

A recent survey, conducted by the Department for International Development, highlighted that more than 70% of people in the UK wanted their own investments to achieve good for people and the planet. This sentiment is perfectly aligned with Micregen’s ambition.

Investing for positive impact goes beyond avoiding harm and mitigating risks, and is at the centre of a wider movement towards more responsible investing.

For Investors we feel that Micregen meet all the following criteria:
  • Disruptive first in class opportunity
  • Proprietary technology with potentially wide utility across diseases
  • Significant global market potential
  • EIS Relief for qualifying investors
  • Ambitious strategy to address areas of high unmet need
  • Highly scalable
  • Experienced and committed team capitalising on the founders’ lifetimes work
  • An ethical business, aiming to improve and save millions of lives
We look forward to contact from anyone who shares our values, ambition and passion for healthcare of the future

Micregen does not make any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein and therein shall not have any liability for such information. Neither this website nor any link in this website to other information constitutes an offer or invitation for the sale or purchase of securities. The information set out herein and therein is preliminary and should not be relied upon for any purpose.